| TRADING CENTER |
| U.S. Food and Drug Administration Approves ABILIFYŽ (aripiprazole) for the Treatment... - Business Wire | |
| Pozen Initiates New Phase III - Analyst Blog - Zacks.com | |
| AstraZeneca Seeks FDA Approval - Analyst Blog - Zacks.com | |
| Critical Alerts for Chevron, Bristol-Myers Squibb, Gold Fields, Novellus, and Host Ho... - PR Newswire | |
| Jim Cramer's Portfolios of the Week - at TheStreet.com | |
| AstraZeneca bets on a blood drug with multibillion-dollar potential - DailyFinance | |
| Healthcare stocks not unduly hurt by Senate plan - Reuters | |
| Allergan, Medicis fall on health plan proposal - Reuters | |
| Your Heart or Your Stomach? - MotleyFool.com | |
| Boehringer clot drug poses small bleed risk-study - Reuters | |
| Astra drug shows faster onset/offset than Plavix - Reuters | |
| Up 80%, It's Time to Sell - MotleyFool.com | |
| Dividend Stocks for the Week - at TheStreet.com | |
| UPDATE: FDA Warns Doctors On Using Plavix With Heartburn Meds - Dow Jones | |
| FDA warns heartburn drugs interfere with Plavix - Reuters |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 62.31 | -0.12 / -0.19% | 13.60 |
| PFE | Pfizer Inc | 18.36 | 0.25 / 1.38% | 15.43 |
| NVS | Novartis AG | 53.13 | -0.16 / -0.30% | 14.92 |
| 2008 Revenue: | $20.6 B | Headquarters: New York, NY |
| Employees: | 35,000 | CEO: James M. Cornelius |
| Net Income: | $5.2 B | Industry: Pharmaceuticals |
| Market Cap: | $48.5 B | Website: www.bms.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| BMY | 24.46 | +0.43 / +1.79% | 24.03 | 24.50 | 23.89 | Profile Chart News |